Synaptic vesicles are synthesized at a rapid rate in nerve terminals t
o compensate for their rapid loss during neurotransmitter release. The
ir biogenesis involves endocytosis of synaptic vesicle membrane protei
ns from the plasma membrane and requires two steps, the segregation of
synaptic vesicle membrane proteins from other cellular proteins, and
the packaging of those unique proteins into vesicles of the correct si
ze. By labeling an epitope-tagged variant of a synaptic vesicle protei
n, VAMP (synaptobrevin), at the cell surface of the neuroendocrine cel
l line PC12, synaptic vesicle biogenesis could be followed with consid
erable precision, quantitatively and kinetically. Epitope-tagged VAMP
was recovered in synaptic vesicles within a few minutes of leaving the
cell surface, More efficient targeting was obtained by using the VAMP
mutant, del 61-70. Synaptic vesicles did not form at 15 degrees C alt
hough endocytosis still occurred. Synaptic vesicles could be generated
in vitro from a homogenate of cells labeled at 15 degrees C. The newl
y formed vesicles are identical to those formed in vivo in their sedim
entation characteristics, the presence of the synaptic vesicle protein
synaptophysin, and the absence of detectable transferrin receptor. Br
ain, but not fibroblast cytosol, allows vesicles of the correct size t
o form. Vesicle formation is time and temperature-dependent, requires
ATP, is calcium independent, and is inhibited by GTP-gamma S. Thus, tw
o key steps in synaptic vesicle biogenesis have been reconstituted in
vitro, allowing direct analysis of the proteins involved.